MEDI
·NYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
24.18MUSD
Fund Flows (1Y)
2.90MUSD
Dividend Yield
0.24%
Discount/Premium to NAV
-0.08%
Shares Outstanding
775.00K
Expense Ratio
0.80%
About Harbor Health Care ETF
Issuer
Harbor Capital Advisors, Inc.
Brand
Harbor
Inception Date
Nov 16, 2022
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Harbor Capital Advisors, Inc.
Distributor
Foreside Fund Services LLC
MEDI invests in a narrow portfolio of 30 to 50 stocks from around the world within the broad health care sector. Companies may include manufacturers of health care equipment, service providers, pharmaceuticals, biotechnology, and health care technology. Securities are selected based on the advisor's assessment of both quantitative and qualitative data. Fundamental criteria considered concentrates on a company's valuation, financial metrics, competitive advantage, market opportunity, capital structure management record and may include other metrics obtained through personal interviews with a company. The advisor believes that superior management, insider ownership, unique market positions, broad market opportunity, solid accounting and financial operations can supplement capital growth.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Active
Geography
Global
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -1.65% | +10.60% | +24.55% | +24.82% | +55.96% | +57.89% |
NAV Total Return | +0.67% | +8.58% | +23.98% | +19.30% | +54.82% | +0.32% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
81.76%
18.24%
Category
Ratio
North America
81.76%
Europe
18.24%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
19.20%
ASND
Ascendis Pharma
15.72%
ABBV
Abbvie
6.77%
LEGN
Legend Biotech
5.58%
MASI
Masimo
4.27%
PCVX
Vaxcyte
3.83%
RVMD
Revolution Medicines
3.53%
UNH
UnitedHealth Group
3.49%
ADMA
ADMA Biologics
2.69%
NTRA
Natera
2.63%
Top 10 Weight 67.71%
38 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-19 | 2025-12-19 | 2025-12-24 | 0.063 |
| 2024-12-20 | 2024-12-20 | 2024-12-26 | 0.097 |
| 2023-12-21 | 2023-12-22 | 2023-12-27 | 0.164 |
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
